1. Home
  2. GRBK vs AXNX Comparison

GRBK vs AXNX Comparison

Compare GRBK & AXNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRBK
  • AXNX
  • Stock Information
  • Founded
  • GRBK 2006
  • AXNX 2012
  • Country
  • GRBK United States
  • AXNX United States
  • Employees
  • GRBK N/A
  • AXNX N/A
  • Industry
  • GRBK Homebuilding
  • AXNX Medical/Dental Instruments
  • Sector
  • GRBK Consumer Discretionary
  • AXNX Health Care
  • Exchange
  • GRBK Nasdaq
  • AXNX Nasdaq
  • Market Cap
  • GRBK 3.3B
  • AXNX 3.6B
  • IPO Year
  • GRBK N/A
  • AXNX N/A
  • Fundamental
  • Price
  • GRBK $82.01
  • AXNX $70.30
  • Analyst Decision
  • GRBK Hold
  • AXNX Hold
  • Analyst Count
  • GRBK 2
  • AXNX 9
  • Target Price
  • GRBK $65.50
  • AXNX $70.67
  • AVG Volume (30 Days)
  • GRBK 350.3K
  • AXNX 521.3K
  • Earning Date
  • GRBK 10-30-2024
  • AXNX 10-28-2024
  • Dividend Yield
  • GRBK N/A
  • AXNX N/A
  • EPS Growth
  • GRBK 26.47
  • AXNX N/A
  • EPS
  • GRBK 7.27
  • AXNX N/A
  • Revenue
  • GRBK $1,877,329,000.00
  • AXNX $408,809,000.00
  • Revenue This Year
  • GRBK $21.00
  • AXNX $25.48
  • Revenue Next Year
  • GRBK $6.28
  • AXNX $19.56
  • P/E Ratio
  • GRBK $11.30
  • AXNX N/A
  • Revenue Growth
  • GRBK 7.44
  • AXNX 27.81
  • 52 Week Low
  • GRBK $37.31
  • AXNX $48.30
  • 52 Week High
  • GRBK $84.66
  • AXNX $70.53
  • Technical
  • Relative Strength Index (RSI)
  • GRBK 57.02
  • AXNX 70.24
  • Support Level
  • GRBK $76.00
  • AXNX $70.17
  • Resistance Level
  • GRBK $84.66
  • AXNX $70.33
  • Average True Range (ATR)
  • GRBK 2.05
  • AXNX 0.28
  • MACD
  • GRBK -0.01
  • AXNX 0.04
  • Stochastic Oscillator
  • GRBK 69.40
  • AXNX 83.92

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title, through its subsidiaries.

About AXNX Axonics Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

Share on Social Networks: